AstraZeneca, Merck Drug Approved for Painful Childhood Ailment

(Bloomberg) -- AstraZeneca Plc and Merck & Co. received U.S. approval for a drug to treat a painful, damaging condition that afflicts children with a rare nerve-cell cancer.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.